Should Aspirin Be Used for Primary Prevention in the Post-Statin Era?

Volume: 379, Issue: 16, Pages: 1572 - 1574
Published: Oct 18, 2018
Abstract
Between 1853 and 1897, German chemists learned to efficiently combine sodium salicylate with acetyl chloride to produce acetylsalicylic acid. That compound, trademarked as aspirin, proved to be a remarkable antiinflammatory and antithrombotic agent and one of the most widely used drugs in pharmaceutical history. As the medical community’s understanding of platelet biology and atherothrombosis evolved, it became clear that aspirin was highly...
Paper Details
Title
Should Aspirin Be Used for Primary Prevention in the Post-Statin Era?
Published Date
Oct 18, 2018
Volume
379
Issue
16
Pages
1572 - 1574
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.